Vident Investment Advisory, LLC Omeros Corp Transaction History

Vident Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.92 - $6.28 $38,413 - $125,643	-20,007 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.07 - $7.2 $20,721 - $29,426	-4,087 Reduced 16.96%	20,007 $120,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $8.54 $136,612 - $205,762	24,094 New	24,094 $155,000
Q3 2021 Nov 12, 2021	SELL	$13.4 - $16.3 $183,151 - $222,788	-13,668 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$14.81 - $19.13 $202,423 - $261,468	13,668 New	13,668 $203,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $627M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.